RENAISSANCE CAPITAL PARTNERS LTD enters TC BIOPHARM (HOLDINGS) PLC with 3.34M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 4/27/2022ACC: 0001920179-22-000001
10% Owner
Since Feb 2022
3.34M
Baseline shares
100% direct
3.34M
Direct ownership
1 position
5.31M
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Ordinary Shares [ADS]
DirectShares owned3.34M
Total
3.34M direct3.34M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares [ADS] | 3.34M | Direct |
| Total | 3.34M | 3.34M direct |
Derivative Holdings1
Warrants
DirectUnderlying security
Ordinary Shares
Underlying shares
5.31M
Shares owned
N/A
Exercise price
4.25
Expiration
—
Exercise window
—
Total
Underlying
5.31M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrants Direct | Ordinary Shares | 4.25 | — | — | 5.31M | N/A |
| Total | 5.31M | 0.00 | ||||